DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
DaVita Inc. (NYSE: DVA) announced its participation in the UBS Global Healthcare Conference 2024 on November 12, 2024. CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat at 12:30 pm PST.
DaVita is a leading kidney care provider serving 265,400 patients across 3,113 outpatient dialysis centers globally, with 2,660 centers in the United States and 453 centers in 13 other countries as of September 30, 2024. The company specializes in comprehensive kidney care services, from disease progression management to transplantation support and home dialysis, maintaining a 20-year track record of clinical excellence and innovation.
DaVita Inc. (NYSE: DVA) ha annunciato la sua partecipazione all'UBS Global Healthcare Conference 2024 che si terrà il 12 novembre 2024. Il CFO Joel Ackerman e il VP del Gruppo delle Relazioni con gli Investitori Nic Eliason parteciperanno a un'intervista informale alle 12:30 PST.
DaVita è un fornitore leader di assistenza per i problemi renali che serve 265.400 pazienti in 3.113 centri di dialisi ambulatoriale a livello globale, con 2.660 centri negli Stati Uniti e 453 centri in altri 13 paesi al 30 settembre 2024. L'azienda si specializza in servizi completi di assistenza renale, dalla gestione della progressione della malattia al supporto per il trapianto e alla dialisi a domicilio, mantenendo un track record di 20 anni di eccellenza clinica e innovazione.
DaVita Inc. (NYSE: DVA) anunció su participación en la UBS Global Healthcare Conference 2024 que se llevará a cabo el 12 de noviembre de 2024. El CFO Joel Ackerman y el VP del Grupo de Relaciones con Inversores Nic Eliason participarán en una charla informal a las 12:30 pm PST.
DaVita es un proveedor líder de cuidado renal que atiende a 265,400 pacientes en 3,113 centros de diálisis ambulatorias en todo el mundo, teniendo 2,660 centros en los Estados Unidos y 453 centros en otros 13 países hasta el 30 de septiembre de 2024. La empresa se especializa en servicios integrales de cuidado renal, desde la gestión del progreso de la enfermedad hasta el apoyo para el trasplante y la diálisis en casa, manteniendo un historial de 20 años de excelencia clínica e innovación.
DaVita Inc. (NYSE: DVA)는 2024년 11월 12일에 개최되는 UBS Global Healthcare Conference 2024에 참여할 것이라고 발표했습니다. CFO Joel Ackerman과 투자 관계 그룹 부사장 Nic Eliason이 오후 12시 30분 PST에 파이어사이드 챗에 참여할 예정입니다.
DaVita는 265,400명의 환자에게 서비스를 제공하는 3,113개의 외래 진료소를 보유한 세계적 신장 관리 제공업체입니다. 2024년 9월 30일 기준으로 미국에 2,660개 센터와 13개국에 453개 센터가 있습니다. 이 회사는 질병 진행 관리, 이식 지원 및 자택 투석을 포함한 포괄적인 신장 관리 서비스를 전문으로 하며, 20년간의 임상 우수성과 혁신 기록을 유지하고 있습니다.
DaVita Inc. (NYSE: DVA) a annoncé sa participation à la UBS Global Healthcare Conference 2024 qui aura lieu le 12 novembre 2024. Le CFO Joel Ackerman et le VP du Groupe des Relations avec les Investisseurs Nic Eliason participeront à une discussion informelle à 12h30 PST.
DaVita est un fournisseur de soins rénaux de premier plan, servant 265 400 patients à travers 3 113 centres de dialyse ambulatoire dans le monde, avec 2 660 centres aux États-Unis et 453 centres dans 13 autres pays au 30 septembre 2024. L'entreprise se spécialise dans des services complets de soins rénaux, allant de la gestion de la progression de la maladie au soutien à la transplantation et à la dialyse à domicile, maintenant une expérience de 20 ans d'excellence clinique et d'innovation.
DaVita Inc. (NYSE: DVA) gab seine Teilnahme an der UBS Global Healthcare Conference 2024 bekannt, die am 12. November 2024 stattfindet. CFO Joel Ackerman und der Gruppen-VP für Investor Relations Nic Eliason werden um 12:30 Uhr PST an einem Fireside-Chat teilnehmen.
DaVita ist ein führender Anbieter von Nierenpflegediensten und betreut 265.400 Patienten in 3.113 ambulanten Dialysezentren weltweit, darunter 2.660 Zentren in den USA und 453 Zentren in 13 weiteren Ländern (Stand 30. September 2024). Das Unternehmen hat sich auf umfassende Nierenpflegedienste spezialisiert, von der Krankheitsprogressionsverwaltung bis zur Unterstützung bei Transplantationen und häuslicher Dialyse, und verfügt über eine 20-jährige Erfolgsgeschichte in klinischer Exzellenz und Innovation.
- None.
- None.
To view the live webcast, visit the UBS page here and create a free registration.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, of which 2,660 centers were located in the United States and 453 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-ubs-global-healthcare-conference-2024-302300393.html
SOURCE DaVita
FAQ
When is DaVita (DVA) presenting at the UBS Global Healthcare Conference 2024?
How many dialysis centers does DaVita (DVA) operate as of September 2024?
How many patients does DaVita (DVA) serve globally?
Who will represent DaVita (DVA) at the UBS Global Healthcare Conference 2024?
